company background image
3737 logo

Zhongzhi Pharmaceutical Holdings Informe acción SEHK:3737

Último precio

HK$1.19

Capitalización de mercado

HK$1.0b

7D

0.8%

1Y

2.6%

Actualizada

06 May, 2024

Datos

Finanzas de la empresa

Zhongzhi Pharmaceutical Holdings Limited

Informe acción SEHK:3737

Capitalización de mercado: HK$1.0b

Resumen de acción 3737

Zhongzhi Pharmaceutical Holdings Limited, sociedad de cartera de inversiones, se dedica a la investigación, desarrollo, fabricación y venta de productos farmacéuticos en la República Popular China.

3737 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends2/6

Competidores de Zhongzhi Pharmaceutical Holdings Limited

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for Zhongzhi Pharmaceutical Holdings
Historical stock prices
Current Share PriceHK$1.19
52 Week HighHK$1.56
52 Week LowHK$0.92
Beta0.64
1 Month Change4.39%
3 Month Change-10.53%
1 Year Change2.59%
3 Year Change-13.77%
5 Year Change-22.22%
Change since IPO-50.21%

Noticias y actualizaciones recientes

Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

May 05
Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Apr 21
Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Recent updates

Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

May 05
Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Apr 21
Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Prospects Need A Boost To Lift Shares

Feb 01
Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Prospects Need A Boost To Lift Shares

These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

May 24
These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?

Aug 26
Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?

Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet

Apr 28
Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet

These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

Jun 11
These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

Investors Met With Slowing Returns on Capital At Zhongzhi Pharmaceutical Holdings (HKG:3737)

May 06
Investors Met With Slowing Returns on Capital At Zhongzhi Pharmaceutical Holdings (HKG:3737)

Zhongzhi Pharmaceutical Holdings (HKG:3737) Strong Profits May Be Masking Some Underlying Issues

Apr 21
Zhongzhi Pharmaceutical Holdings (HKG:3737) Strong Profits May Be Masking Some Underlying Issues

Do Zhongzhi Pharmaceutical Holdings's (HKG:3737) Earnings Warrant Your Attention?

Mar 29
Do Zhongzhi Pharmaceutical Holdings's (HKG:3737) Earnings Warrant Your Attention?

The Zhongzhi Pharmaceutical Holdings (HKG:3737) Share Price Has Gained 50% And Shareholders Are Hoping For More

Mar 05
The Zhongzhi Pharmaceutical Holdings (HKG:3737) Share Price Has Gained 50% And Shareholders Are Hoping For More

Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

Feb 15
Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

What Is The Ownership Structure Like For Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)?

Jan 14
What Is The Ownership Structure Like For Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)?

Would Zhongzhi Pharmaceutical Holdings Limited (HKG:3737) Be Valuable To Income Investors?

Dec 27
Would Zhongzhi Pharmaceutical Holdings Limited (HKG:3737) Be Valuable To Income Investors?

If You Like EPS Growth Then Check Out Zhongzhi Pharmaceutical Holdings (HKG:3737) Before It's Too Late

Dec 14
If You Like EPS Growth Then Check Out Zhongzhi Pharmaceutical Holdings (HKG:3737) Before It's Too Late

Did You Miss Zhongzhi Pharmaceutical Holdings' (HKG:3737) 31% Share Price Gain?

Nov 30
Did You Miss Zhongzhi Pharmaceutical Holdings' (HKG:3737) 31% Share Price Gain?

Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

Nov 17
Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

Rentabilidad de los accionistas

3737HK PharmaceuticalsMercado HK
7D0.8%3.5%2.4%
1Y2.6%-12.5%-8.7%

Rentabilidad vs. Industria: 3737 superó al sector Hong Kong Pharmaceuticals , que obtuvo un rendimiento del -15.9% el año pasado.

Rentabilidad vs. Mercado: 3737 superó al mercado Hong Kong, que obtuvo un rendimiento del -10.1% el año pasado.

Volatilidad de los precios

Is 3737's price volatile compared to industry and market?
3737 volatility
3737 Average Weekly Movement6.5%
Pharmaceuticals Industry Average Movement6.1%
Market Average Movement7.4%
10% most volatile stocks in HK Market15.0%
10% least volatile stocks in HK Market3.6%

Precio estable de las acciones: 3737 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de 3737 (7%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
19932,643Ying Feng Laiwww.zeus.cn

Zhongzhi Pharmaceutical Holdings Limited, un holding de inversiones, se dedica a la investigación, desarrollo, fabricación y venta de productos farmacéuticos en la República Popular China. La empresa opera a través de los segmentos de Fabricación Farmacéutica y Explotación de Cadenas de Farmacias. Suministra medicamentos chinos patentados y piezas de decocción bajo las marcas Zeus, Liumian y Caojinghua.

Resumen de fundamentos de Zhongzhi Pharmaceutical Holdings Limited

¿Cómo se comparan los beneficios e ingresos de Zhongzhi Pharmaceutical Holdings con su capitalización de mercado?
Estadísticas fundamentales de 3737
Capitalización bursátilHK$1.03b
Beneficios(TTM)HK$176.36m
Ingresos (TTM)HK$2.22b

5.8x

Ratio precio-beneficio (PE)

0.5x

Ratio precio-ventas (PS)

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de 3737
IngresosCN¥2.05b
Coste de los ingresosCN¥835.21m
Beneficio brutoCN¥1.21b
Otros gastosCN¥1.05b
BeneficiosCN¥162.78m

Últimos beneficios comunicados

Dec 31, 2023

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)0.19
Margen bruto59.25%
Margen de beneficio neto7.94%
Ratio deuda/patrimonio4.7%

¿Cómo se ha desempeñado 3737 a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

5.0%

Rentabilidad actual por dividendo

43%

Ratio de pagos
¿Cuándo hay que comprar 3737 para recibir un próximo dividendo?
fechas de dividendos de Zhongzhi Pharmaceutical Holdings
Fecha ex dividendoMay 24 2024
Fecha de pago de dividendosJun 13 2024
Días hasta ex dividendo17 days
Días hasta la fecha de pago de dividendos37 days